Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Clinical trial NCT06548542 · RECRUITING

Trial details

NCT number: NCT06548542
Sponsor: AbbVie
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2024-09-04
Primary completion: 2030-01-01
Enrollment: 540

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.